Dld Asset Management, LP Pacific Biosciences Of California, Inc. Transaction History

Dld Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$2.36 - $5.26 $1.42 Million - $3.16 Million	-600,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $1.84 Million - $2.23 Million	-400,000 Reduced 40.0%	600,000 $3.08 Million
Q3 2019 Nov 12, 2019	SELL	$4.99 - $6.16 $2.5 Million - $3.08 Million	-500,000 Reduced 33.33%	1,000,000 $5.16 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $651,200 - $815,100	110,000 Added 7.91%	1,500,000 $9.08 Million
Q1 2019 May 14, 2019	SELL	$6.8 - $7.4 $2.33 Million - $2.54 Million	-343,340 Reduced 19.81%	1,390,000 $10.1 Million
Q4 2018 Feb 13, 2019	BUY	$3.99 - $7.82 $6.92 Million - $13.6 Million	1,733,340 New	1,733,340 $12.8 Million

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.